A detailed history of Charles Schwab Investment Management Inc transactions in Galectin Therapeutics Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 65,073 shares of GALT stock, worth $56,613. This represents 0.0% of its overall portfolio holdings.

Number of Shares
65,073
Previous 65,073 -0.0%
Holding current value
$56,613
Previous $147,000 21.09%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$2.13 - $4.2 $101,515 - $200,172
47,660 Added 273.7%
65,073 $147,000
Q2 2021

Aug 16, 2021

SELL
$2.07 - $5.1 $124,355 - $306,382
-60,075 Reduced 77.53%
17,413 $56,000
Q1 2021

May 17, 2021

SELL
$1.96 - $2.57 $15,705 - $20,593
-8,013 Reduced 9.37%
77,488 $169,000
Q3 2020

Nov 13, 2020

SELL
$2.53 - $3.64 $18,818 - $27,074
-7,438 Reduced 8.0%
85,501 $229,000
Q2 2020

Aug 14, 2020

BUY
$1.66 - $3.15 $821 - $1,559
495 Added 0.54%
92,939 $285,000
Q3 2019

Nov 08, 2019

BUY
$3.0 - $4.05 $52,056 - $70,275
17,352 Added 23.11%
92,444 $340,000
Q2 2019

Aug 09, 2019

BUY
$3.61 - $5.0 $271,082 - $375,460
75,092 New
75,092 $312,000
Q2 2018

Aug 08, 2018

SELL
$3.16 - $9.16 $67,624 - $196,024
-21,400 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$1.67 - $2.3 $35,738 - $49,219
21,400
21,400 $46,000

Others Institutions Holding GALT

About GALECTIN THERAPEUTICS INC


  • Ticker GALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,426,000
  • Market Cap $51.7M
  • Description
  • Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...
More about GALT
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.